Factual, unbiased, and essential
pandemic news from trusted sources around the globe.
(Udpated 5:15PM PST)
There are some new updates regarding a mutation to the coronavirus, which show that the new mutation may not actually make people more sick. Unfortunately, however, it may make it easier to contract the illness.
According to an update on CNN,
"A global study has found clear evidence that a new form of the coronavirus has spread from Europe to the US. The new mutation makes the virus more infectious but does not seem to make people any sicker, an international team of researchers reported Thursday.
The mutation affects the spike protein — the structure the virus uses to get into the cells it infects. Now the researchers are checking to see if this affects whether the virus can be controlled by a vaccine. Current vaccines being tested mostly target the spike protein.
The study, published in the journal Cell, confirms earlier work suggesting the mutation had made the new variant of virus more common. The researchers call the new mutation G614, and they show that it has almost completely replaced the first version to spread in Europe and the US, one called D614.
“Our global tracking data show that the G614 variant in Spike has spread faster than D614,” theoretical biologist Bette Korber of Los Alamos National Laboratory and colleagues wrote in their report. “We interpret this to mean that the virus is likely to be more infectious,” they add. “Interestingly, we did not find evidence of G614 impact on disease severity.”
Additionally, an update on the Washington Post explains the following in regards to a vaccine with coronavirus mutations:
"Francis Collins, the director of the National Institutes of Health, testified before a Senate subcommittee Thursday that the novel coronavirus is very different from viruses that mutate rapidly to evade therapeutic and treatment strategies.
“The good news is this is not like HIV. This is not like influenza,” Collins said. “It’s a fairly well-behaved virus that we think we ought to be able to tackle effectively with a vaccine strategy.”
A genetic variant of the coronavirus has gained scientific attention and concern because of evidence in laboratory studies that it may be better at infecting cells. But Collins explained that the coronavirus has a slow mutation rate and underscored that none of the variants detected appear to be threats to the effectiveness of treatments and vaccines being developed.
Click here to access and to read more CNN Updates for 7/2/2020.
Click here to access and to read more Washington Post updates for 7/2/2020.
(Another article published Thursday evening on CNN explains this subject more in depth. Click here.)